I started following BioRunUp a month or two before it became a paid site, in late 2010 . Once he switched to a paid site, I used the gains from his free advice to pay for a yearly subscription and I’m so glad I did. Since then he has been improving the website and services constantly. The four best things I like about the service are: the transparency, BioRunUps accessibility, the wealth of information and trading ideas, and the versatility of trading options.
All trades are tweeted real time, giving the number of shares and price. All current positions are listed on the website with number of shares and price paid. He also gives you an idea of what he’s looking to buy next by posting a watch list, mentioning them in bi-weekly webinars, and updating a catalyst roadmap with planned buys and sells by month. In my opinion, the most helpful component are the trading game plan videos that spell out step by step how he plans to trade an upcoming catalyst event.
BioRunUp is in the chat room every single day, sometimes even when he’s on vacation. You can email him anytime, and the few times that I’ve sent him a message, he’s responded the same day. He doesn’t talk down to anyone and takes the time to explain things to those who are new to biotechs or trading in general. The webinars are user-driven, BioRunUp will ask for tickers from members and he’ll talk about the more popular stocks suggested.
There’s a user guide on the website so newbies can get to know the lingo and complicated acronyms. The updated-daily Clinical and Regulatory Catalyst Calendar contains information about hundreds of upcoming biotech catalysts (clinical trial data, FDA Panels, PDUFAs, EU decisions, 510k decisions, and more). The previously mentioned webinars and almost daily articles are good sources to stock information as well.
BioRunUp doesn’t just play long-term, pre-planned catalyst events; he will also play surprise events like shelf filings, stock dilutions, or when clinical data is given a specific release date. Mike, another trader from the service, plays high-risk, high reward clinical trial events. It’s the mixture of low-risk long-term trades combined with high-risk short-term trades that makes it fun to trade with him.
I’m up about 40% in my portfolio this year mostly thanks to the BioRunUp service so I would greatly recommend it. If BioRunUp posts an offer for a free two weeks or discounted month, you should try it out, you will not be disappointed.
This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
2 of 4 people have found this review helpful.
Was this review helpful?